Does cefiderocol heteroresistance explain the discrepancy between the APEKS-NP and CREDIBLE-CR clinical trial results?

Authors:

Abstract
No abstract available
Funding Information
  • National Institute of Allergy and Infectious Diseases
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • US Department of Veterans Affairs
  • Burroughs Wellcome Fund
  • Cystic Fibrosis Foundation
  • National Institutes of Health Office of the Director

This publication has 10 references indexed in Scilit: